Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1ABO & Rh blood groups
  • Track 1-2Blood transfusion
  • Track 1-3Transfusion hazards

Tumour immunology is the interaction between cells of the  the immune system and tumour cells (malignancies)

Tumour immunology is central to our understanding of the mechanisms of both tumour rejection and tumour progression. Virtually every known cell type of the immune system is represented in the tumour microenvironment, but as yet the functional significance of intratumoral effector cells is not fully understood. Moreover, the complex interactions between these immune cells within the tumour have yet to be fully elucidated. Although many individual effector cells have the capacity to kill tumour cells in vitro, they are frequently suppressed within the tumour microenvironment through a range of mechanisms. In this article, the known functions of immune effector cells within the tumour and the suppressive processes limiting the function of those cells are described. The purpose of tumour immunology should be to give us a better understanding of how to manipulate the immune system to fight cancer. Some relevant applications of tumour immunotherapy are therefore described.

  • Track 4-1Skin Immunology
  • Track 4-2Respiratory immunology
  • Track 4-3Gastrointestinal immunology
  • Track 4-4Occular immunology
  • Track 4-5Neuro immunology
  • Track 4-6Osteoimmunology

Clinical immunology is the study of diseases caused by disorders of the immune system. It also involves diseases of other systems, where immune reactions play a part in the pathology and clinical features of immune response. In the Clinical immunology the molecular and cellular bases of immunological disease mostly studied.

Clinical Laboratory Immunology
Immunological Disease
Primary Immunodeficiency

  • Track 7-1Innate immunity
  • Track 7-2Adaptive immunity
  • Track 7-3T-cells & B-cells
  • Track 7-4Lymphoid organs
  • Track 7-5Lymphocyte development & activation
  • Track 7-6Antigen presentation & processing
  • Track 7-7Immune diversity
  • Track 7-8Cellular interactions

  • Track 8-1Antibody structure
  • Track 8-2Antibody classes
  • Track 8-3Antigen response in different tissues
  • Track 8-4Antigen-Antibody complexes

  • Track 9-1Immune Deficiency
  • Track 9-2Hypersensitivity
  • Track 9-3Autoimmune diseases
  • Track 9-4Transplantation & Rejection
  • Track 9-5Immune pharmacotherapy
  • Track 9-6Immunity & Malnutrition
  • Track 9-7HLA system

  • Track 10-1Types of vaccines
  • Track 10-2Vaccine vehicles
  • Track 10-3Vaccine safety
  • Track 10-4Transfusion Alternatives

  • Track 11-1Assays for Antigen & antibody
  • Track 11-2Isolation of cells
  • Track 11-3Monoclonal Antibodies
  • Track 11-4Cytometry
  • Track 11-5DNA Microarrays
  • Track 11-6Measurement of immune function
  • Track 11-7Agglutination tests

  • Track 12-1Immunity to Infection
  • Track 12-2Immunity to viruses
  • Track 12-3Immunity to Bacteria & fungi
  • Track 12-4Immunity to protozoa & worms
  • Track 12-5Microbial immunology
  • Track 12-6Immunogens & Antigens

  • Track 13-1Origin & host defence against tumours
  • Track 13-2Cytokine and cellular immunotherapy of tumours
  • Track 13-3Immune response to tumours
  • Track 13-4Tumour antigens
  • Track 13-5Immuno diagnostics of cancer
  • Track 13-6Tumor vaccines
  • Track 13-7Immunotherapy of tumours with antibodies

  • Track 14-1Cell mediated Immunotherapy
  • Track 14-2Cytokine mediated immunotherapy
  • Track 14-3Antibody mediated immunotherapy
  • Track 14-4Cellular immunotherapy

  • Track 15-1Gene Mapping
  • Track 15-2Genes of immunoglobulin
  • Track 15-3Major Histocompatibility Complex
  • Track 15-4Advances in immunogenetics

  • Track 16-1Tissue damage
  • Track 16-2Disease pathogenesis

  • Track 17-1Central Immune tolerance
  • Track 17-2Pheripheral immune tolerance

  • Track 19-1Clinical Parasitology
  • Track 19-2Infection Control
  • Track 19-3Parasitic Diseases
  • Track 19-4Clinical microbiology

Innate immune responses are not specific to a particular pathogen or non-self-ingredient in the way that the adaptive immune responses are. They depend on a group of proteins and phagocytic cells that recognize conserved features of pathogens and become quickly activated to help destroy invaders. The innate immune system is essentially made up of barriers that aim to keep viruses, bacteria, parasites, and other foreign particles out of your body or limit their ability to spread and move throughout the body.

Defense Mechanisms

General Immune Responses

 Phagocytes & Macrophages

The Complement System

Host-Pathogen Interactions

Pathogen sensing and restriction

Pathological inflammation in response to microbes

  • Track 22-1Immune cells in reproductive tract
  • Track 22-2Sex hormones & immune system
  • Track 22-3Developmental changes in immune system
  • Track 22-4Effect of age on immune system